FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Markku Savolainen

Research Profile

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Tuija Huusko; Tatu Juvonen; Johanna Liinamaa; Paavo Pääkkö; Tuire M Salonurmi; Markku Savolainen; Panu Taskinen; Sakari Kakko
Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
U E Koskela; S M Kuusisto; A E Nissinen; Markku Savolainen; M Johanna Liinamaa
High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy.
S Haghighi Poodeh; P Koivunen; I Nagy; J Räsänen; Tuire M Salonurmi; R Sormunen; Seppo Vainio; Jussi T Vuoristo; Markku Savolainen
Alcohol-induced premature permeability in mouse placenta-yolk sac barriers in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Markku Savolainen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tuija Huusko; Tatu Juvonen; Johanna Liinamaa; Paavo Pääkkö; Tuire M Salonurmi; Markku Savolainen; Panu Taskinen; Sakari Kakko
Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
The Journal of thoracic and cardiovascular surgery 2013;145(4):1117-23.
2013: U E Koskela; S M Kuusisto; A E Nissinen; Markku Savolainen; M Johanna Liinamaa
High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy.
Ophthalmic research 2013;49(2):108-14.
2012: S Haghighi Poodeh; P Koivunen; I Nagy; J Räsänen; Tuire M Salonurmi; R Sormunen; Seppo Vainio; Jussi T Vuoristo; Markku Savolainen
Alcohol-induced premature permeability in mouse placenta-yolk sac barriers in vivo.
Placenta 2012;33(10):866-73.
2012: Timo Paavola; Tuire M Salonurmi; Markku Savolainen; Tuija Huusko; Tiia Maria Kangas-Kontio; Sanna Kuusisto; Sakari Kakko
Plasma levels of antibodies against oxidized LDL are inherited but not associated with HDL-cholesterol level in families with early coronary heart disease.
Atherosclerosis 2012;224(1):123-8.
2012: Sanna M Kuusisto; Maria Laitinen; Ville-Petteri Mäkinen; Tomi Peltola; Tuire M Salonurmi; Markku Savolainen; Minna L Hannuksela; Pirjo Hedberg; Matti Jauhiainen; Linda S Kumpula; Mika Ala-Korpela
The interplay between lipoprotein phenotypes, adiponectin, and alcohol consumption.
Annals of medicine 2012;44(5):513-22.
2012: T Tukiainen; O Gröhn; Per-Henrik Groop; M Hallikainen; P Jylänki; Kimmo Kaski; M Kivipelto; Ville-Petteri Mäkinen; Tuula Pirttilä; Markku Savolainen; H Soininen; Pasi Soininen; Mika Ala-Korpela
Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses.
The journal of nutrition, health & aging 2012;16(7):631-5.
2011: Peter Würtz; Pasi Soininen; Antti J Kangas; Ville-Petteri Mäkinen; Per-Henrik Groop; Markku Savolainen; Markus Juonala; Jorma S Viikari; Mika Kähönen; Terho Lehtimäki; Olli T Raitakari; Mika Ala-Korpela
Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis.
Molecular bioSystems 2011;7(2):385-93.
2011: Anna-Maria Keränen; Katrin Strengell; Markku Savolainen; Jaana H Laitinen
Effect of weight loss intervention on the association between eating behaviour measured by TFEQ-18 and dietary intake in adults.
Appetite 2011;56(1):156-62.
2010: Anna-Maria Keränen; Elsi Rasinaho; Helinä Hakko; Markku Savolainen; Sari Lindeman
Eating behavior in obese and overweight persons with and without anhedonia.
Appetite 2010;55(3):726-9.
2010: Elizabeth K Speliotes; Cristen J Willer; Sonja I Berndt; Keri L Monda; Gudmar Thorleifsson; Anne U Jackson; Cecilia M Lindgren; Jian'an Luan; Reedik Mägi; Joshua C Randall; Sailaja Vedantam; Thomas W Winkler; Lu Qi; Tsegaselassie Workalemahu; Iris M Heid; Valgerdur Steinthorsdottir; Heather M Stringham; Michael N Weedon; Eleanor Wheeler; Andrew R Wood; Teresa Ferreira; Robert J Weyant; Ayellet V Segrè; Karol Estrada; Liming Liang; James Nemesh; Ju-Hyun Park; Stefan Gustafsson; Tuomas O Kilpeläinen; Jian Yang; Nabila Bouatia-Naji; Tõnu Esko; Mary F Feitosa; Zoltan Kutalik; Massimo Mangino; Soumya Raychaudhuri; Andre Scherag; Albert Vernon Smith; Ryan Welch; Jing Hua Zhao; Katja K Aben; Devin M Absher; Najaf Amin; Anna L Dixon; Eva Fisher; Nicole L Glazer; Michael E Goddard; Nancy L Heard-Costa; Volker Hoesel; Jouke-Jan Hottenga; Asa Johansson; Toby Johnson; Shamika Ketkar; Claudia Lamina; Shengxu Li; Miriam F Moffatt; Richard H Myers; Narisu Narisu; John R B Perry; Marjolein J Peters; Michael Preuss; Samuli Ripatti; Fernando Rivadeneira; Camilla Sandholt; Laura J Scott; Nicholas J Timpson; Jonathan P Tyrer; Sophie van Wingerden; Richard M Watanabe; Charles C White; Fredrik Wiklund; Christina Barlassina; Daniel I Chasman; Matthew N Cooper; John-Olov Jansson; Robert W Lawrence; Niina Pellikka; Inga Prokopenko; Jianxin Shi; Elisabeth Thiering; Helene Alavere; Maria T S Alibrandi; Peter Almgren; Alice M Arnold; Thor Aspelund; Larry D Atwood; Beverley Balkau; Anthony J Balmforth; Amanda J Bennett; Yoav Ben-Shlomo; Richard N Bergman; Sven Bergmann; Heike Biebermann; Alexandra I F Blakemore; Tanja Boes; Lori L Bonnycastle; Stefan R Bornstein; Morris J Brown; Thomas A Buchanan; Fabio Busonero; Harry Campbell; Francesco P Cappuccio; Christine Cavalcanti-Proença; Yii-Der Ida Chen; Chih-Mei Chen; Peter S Chines; Robert Clarke; Lachlan Coin; John Connell; Ian N M Day; Jubao Duan; Shah Ebrahim; Paul Elliott; Roberto Elosua; Gudny Eiriksdottir; Michael R Erdos; Johan G Eriksson; Maurizio F Facheris; Stephan B Felix; Pamela Fischer-Posovszky; Aaron R Folsom; Nele Friedrich; Nelson B Freimer; Mao Fu; Stefan Gaget; Pablo V Gejman; Eco J C Geus; Christian Gieger; Anette P Gjesing; Anuj Goel; Philippe Goyette; Harald Grallert; Jürgen Grässler; Danielle M Greenawalt; Christopher J Groves; Vilmundur Gudnason; Candace Guiducci; Anna-Liisa Hartikainen; Neelam Hassanali; Alistair Hall; Aki S Havulinna; Caroline Hayward; Andrew C Heath; Christian Hengstenberg; Andrew A Hicks; Anke Hinney; Albert Hofman; Georg Homuth; Jennie Hui; Wilmar Igl; Carlos Iribarren; Bo Isomaa; Kevin B Jacobs; Ivonne Jarick; Elizabeth Jewell; Ulrich John; Torben Jørgensen; Pekka Jousilahti; Antti Jula; Marika Kaakinen; Eero Kajantie; Lee M Kaplan; Sekar Kathiresan; Johannes Kettunen; Leena Kinnunen; Joshua W Knowles; Ivana Kolcic; Inke R König; Seppo Koskinen; Peter Kovacs; Johanna Kuusisto; Peter Kraft; Kirsti Kvaløy; Jaana Laitinen; Olivier Lantieri; Chiara Lanzani; Lenore J Launer; Cecile Lecoeur; Terho Lehtimäki; Guillaume Lettre; Jianjun Liu; Marja-Liisa Lokki; Mattias Lorentzon; Robert N Luben; Barbara Ludwig; Paolo Manunta; Diana Marek; Michel Marre; Nicholas G Martin; Wendy L McArdle; Anne McCarthy; Barbara McKnight; Thomas Meitinger; Olle Melander; David Meyre; Kristian Midthjell; Grant W Montgomery; Mario A Morken; Andrew P Morris; Rosanda Mulic; Julius S Ngwa; Mari Nelis; Matt J Neville; Dale R Nyholt; Christopher J O'Donnell; Stephen O'Rahilly; Ken K Ong; Ben Oostra; Guillaume Paré; Alex N Parker; Markus Perola; Irene Pichler; Kirsi H Pietiläinen; Carl G P Platou; Ozren Polasek; Anneli Pouta; Suzanne Rafelt; Olli Raitakari; Nigel W Rayner; Martin Ridderstråle; Winfried Rief; Aimo Ruokonen; Neil R Robertson; Peter Rzehak; Veikko Salomaa; Alan R Sanders; Manjinder S Sandhu; Serena Sanna; Jouko Saramies; Markku Savolainen; Susann Scherag; Sabine Schipf; Stefan Schreiber; Heribert Schunkert; Kaisa Silander; Juha Sinisalo; David S Siscovick; Jan H Smit; Nicole Soranzo; Ulla Sovio; Jonathan Stephens; Ida Surakka; Amy J Swift; Mari-Liis Tammesoo; Jean-Claude Tardif; Maris Teder-Laving; Tanya M Teslovich; John R Thompson; Brian Thomson; Anke Tönjes; Tiinamaija Tuomi; Joyce B J van Meurs; Gert-Jan van Ommen; Vincent Vatin; Jorma Viikari; Sophie Visvikis-Siest; Veronique Vitart; Carla I G Vogel; Benjamin F Voight; Lindsay L Waite; Henri Wallaschofski; Gudmundur Bragi Walters; Elisabeth Widen; Susanna Wiegand; Sarah H Wild; Gonneke Willemsen; Daniel R Witte; Jacqueline C Witteman; Jianfeng Xu; Qunyuan Zhang; Lina Zgaga; Andreas Ziegler; Paavo Zitting; John P Beilby; I Sadaf Farooqi; Johannes Hebebrand; Heikki V Huikuri; Alan L James; Mika Kähönen; Douglas F Levinson; Fabio Macciardi; Markku S Nieminen; Claes Ohlsson; Lyle J Palmer; Paul M Ridker; Michael Stumvoll; Jacques Beckmann; Heiner Boeing; Eric Boerwinkle; Dorret I Boomsma; Mark J Caulfield; STEPHEN CHANOCK; Francis S Collins; L Adrienne Cupples; George Davey Smith; Jeanette Erdmann; Philippe Froguel; Henrik Grönberg; Ulf Gyllensten; Per Hall; Torben Hansen; Tamara B Harris; Andrew T Hattersley; Richard B Hayes; Joachim Heinrich; Frank B Hu; Kristian Hveem; Thomas Illig; Marjo-Riitta Jarvelin; Jaakko Kaprio; Fredrik Karpe; Kay-Tee Khaw; Lambertus A Kiemeney; Heiko Krude; Markku Laakso; Debbie A Lawlor; Andres Metspalu; Patricia B Munroe; Willem H Ouwehand; Oluf Pedersen; Brenda W Penninx; Annette Peters; Peter P Pramstaller; Thomas Quertermous; Thomas Reinehr; Aila Rissanen; Igor Rudan; Nilesh J Samani; Peter E H Schwarz; Alan R Shuldiner; Timothy D Spector; Jaakko Tuomilehto; Manuela Uda; André Uitterlinden; Timo T Valle; Martin Wabitsch; Gérard Waeber; Nicholas J Wareham; Hugh Watkins; James F Wilson; Alan F Wright; M Carola Zillikens; Nilanjan Chatterjee; Steven A McCarroll; Shaun Purcell; Eric E Schadt; Peter M Visscher; Themistocles L Assimes; Ingrid B Borecki; Panos Deloukas; Caroline S Fox; Leif C Groop; Talin Haritunians; David J Hunter; Robert Kaplan; Karen L Mohlke; Jeffrey R O'Connell; Leena Peltonen; David Schlessinger; David P Strachan; Cornelia M van Duijn; H-Erich Wichmann; Timothy M Frayling; Unnur Thorsteinsdottir; Gonçalo R Abecasis; Inês Barroso; Michael Boehnke; Kari Stefansson; Kari E North; Mark I McCarthy; Joel N Hirschhorn; Erik Ingelsson; Martin den Heijer; Hana Lango Allen; Ruth J F Loos
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.
Nature genetics 2010;42(11):937-48.
2010: Tiia Maria Kangas-Kontio; Anne Huotari; Heli Ruotsalainen; Karl-Heinz Herzig; Minna Tamminen; Mika Ala-Korpela; Markku Savolainen; Sakari Kakko
Genetic and environmental determinants of total and high-molecular weight adiponectin in families with low HDL-cholesterol and early onset coronary heart disease.
Atherosclerosis 2010;210(2):479-85.
2010: Tiia Maria Kangas-Kontio; Sakari Kakko; Minna Tamminen; Peter von Rohr; Ina Hoeschele; Tatu Juvonen; Juha Kere; Markku Savolainen
Genome scan for loci regulating HDL cholesterol levels in Finnish extended pedigrees with early coronary heart disease.
European journal of human genetics : EJHG 2010;18(5):604-13.
2010: Hannu J Koponen; Helinä H Hakko; Kaisa M Saari; Sari M Lindeman; Kaisa M Karvonen; Matti K Isohanni; Liisa H Lauren; Markku Savolainen; Marjo-Riitta Järvelin
The prevalence and predictive value of individual criteria for metabolic syndrome in schizophrenia: a Northern Finland 1966 Birth Cohort Study.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2 Pt 2):262-7.
2010: Linda S Kumpula; Sanna M Mäkelä; Ville-Petteri Mäkinen; Anna Karjalainen; Johanna M Liinamaa; Kimmo Kaski; Markku Savolainen; Minna L Hannuksela; Mika Ala-Korpela
Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps.
Journal of lipid research 2010;51(2):431-9.
2010: Reecha Sofat; Aroon D Hingorani; Liam Smeeth; Steve E Humphries; Philippa J Talmud; Jackie Cooper; Tina Shah; Manjinder S Sandhu; Sally L Ricketts; S Matthijs Boekholdt; Nicholas Wareham; Kay Tee Khaw; Meena Kumari; Mika Kivimaki; Michael Marmot; Folkert W Asselbergs; Pim van der Harst; Robin P F Dullaart; Gerjan Navis; Dirk J van Veldhuisen; Wiek H Van Gilst; John F Thompson; Pamela McCaskie; Lyle J Palmer; Marcello Arca; Fabiana Quagliarini; Carlo Gaudio; François Cambien; Viviane Nicaud; Odette Poirer; Vilmundur Gudnason; Aaron Isaacs; Jacqueline C M Witteman; Cornelia M van Duijn; Michael Pencina; Ramachandran S Vasan; Ralph B D'Agostino; Jose Ordovas; Tricia Y Li; Sakari Kakko; Heikki Kauma; Markku Savolainen; Y Antero Kesäniemi; Anton Sandhofer; Bernhard Paulweber; Jose V Sorli; Akimoto Goto; Shinji Yokoyama; Kenji Okumura; Benjamin D Horne; Chris Packard; Dilys Freeman; Ian Ford; Naveed Sattar; Valerie McCormack; Debbie A Lawlor; Shah Ebrahim; George Davey Smith; John J P Kastelein; John Deanfield; Juan P Casas
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms.
Circulation 2010;121(1):52-62.
2010: Ilkka Immonen; Sanna Seitsonen; Petri Tommila; Tiia Maria Kangas-Kontio; Sakari Kakko; Eeva-Riitta Savolainen; Markku Savolainen; M Johanna Liinamaa
Vascular endothelial growth factor gene variation and the response to photodynamic therapy in age-related macular degeneration.
Ophthalmology 2010;117(1):103-8.
2009: Mika Ala-Korpela; Pasi Soininen; Markku Savolainen
Letter by Ala-Korpela et al regarding article, "Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women".
Circulation 2009;120(17):e149; author reply e150.
2009: Tiia Maria Kangas-Kontio; S Vavuli; Sakari Kakko; J Penna; Eeva-Riitta Savolainen; Markku Savolainen; M Johanna Liinamaa
Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
The British journal of ophthalmology 2009;93(10):1401-6.
2009: Pasi Soininen; Antti J Kangas; Peter Würtz; Taru Tukiainen; Tuulia Tynkkynen; Reino Laatikainen; Marjo-Riitta Järvelin; Mika Kähönen; Terho Lehtimäki; Jorma Viikari; Olli T Raitakari; Markku Savolainen; Mika Ala-Korpela
High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism.
The Analyst 2009;134(9):1781-5.
2009: Anna-Maria Keränen; Markku Savolainen; Annakaisa H Reponen; Mona-Lisa Kujari; Sari Lindeman; Risto Bloigu; Jaana H Laitinen
The effect of eating behavior on weight loss and maintenance during a lifestyle intervention.
Preventive medicine 2009;49(1):32-8.
2009: Helena Kastarinen; Sohvi Hörkkö; Heikki Kauma; Anna Karjalainen; Markku Savolainen; Y Antero Kesäniemi
Low-density lipoprotein clearance in patients with chronic renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(7):2131-5.
2009: Marja K Liisanantti; Markku Savolainen
Phosphatidylethanol mediates its effects on the vascular endothelial growth factor via HDL receptor in endothelial cells.
Alcoholism, clinical and experimental research 2009;33(2):283-8.
2009: Janne Hukkanen; Olavi Ukkola; Markku Savolainen
Effects of low-dose liquorice alone or in combination with hydrochlorothiazide on the plasma potassium in healthy volunteers.
Blood pressure 2009;18(4):192-5.
2009: Jaakko Niemi; Ville-Petteri Mäkinen; Jukka Heikkonen; Leena Tenkanen; Yrjö Hiltunen; Minna L Hannuksela; Matti Jauhiainen; Carol Forsblom; Marja-Riitta Taskinen; Y Antero Kesäniemi; Markku Savolainen; Kimmo Kaski; Per-Henrik Groop; Petri T Kovanen; Mika Ala-Korpela
Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes.
Annals of medicine 2009;41(6):451-61.
2009: Tiia Maria Kangas-Kontio; Jari M Tapanainen; Heikki Huikuri; Eeva-Riitta Savolainen; Markku Päivänsalo; Heikki Kauma; Y Antero Kesäniemi; Markku Savolainen; Sakari Kakko
Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction.
Scandinavian journal of clinical and laboratory investigation 2009;69(3):335-43.
2008: Sanna M Mäkelä; Matti Jauhiainen; Mika Ala-Korpela; Jari Metso; Tiina M Lehto; Markku Savolainen; Minna L Hannuksela
HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
Alcoholism, clinical and experimental research 2008;32(6):991-1000.
2008: Antti E Nissinen; Sanna M Mäkelä; Jussi T Vuoristo; Marja K Liisanantti; Minna L Hannuksela; Sohvi Hörkkö; Markku Savolainen
Immunological detection of in vitro formed phosphatidylethanol--an alcohol biomarker--with monoclonal antibodies.
Alcoholism, clinical and experimental research 2008;32(6):921-8.
2008: Hannu Koponen; Antti Alaräisänen; Kaisa Saari; Olavi Pelkonen; Heikki Huikuri; M J Pekka Raatikainen; Markku Savolainen; Matti Isohanni
Schizophrenia and sudden cardiac death: a review.
Nordic journal of psychiatry 2008;62(5):342-5.
2008: M Johanna Liinamaa; Markku Savolainen
High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
Annals of medicine 2008;40(3):209-14.
2007: Teemu Suna; Aino Salminen; Pasi Soininen; Reino Laatikainen; Petri Ingman; Sanna Mäkelä; Markku Savolainen; Minna L Hannuksela; Matti Jauhiainen; Marja-Riitta Taskinen; Kimmo Kaski; Mika Ala-Korpela
1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps.
NMR in biomedicine 2007;20(7):658-72.
2007: Tuija J Huusko; Marja K Liisanantti; Antti E Nissinen; Sakari Kakko; Eeva-Riitta Savolainen; Jussi T Vuoristo; Markku Savolainen
Effects of phosphatidylethanol on mouse adipocyte differentiation and expression of stearoyl-CoA desaturase 1.
Alcoholism, clinical and experimental research 2007;31(3):376-82.
2007: Minna L Hannuksela; Marja K Liisanantti; Antti E T Nissinen; Markku Savolainen
Biochemical markers of alcoholism.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007;45(8):953-61.
2007: Aki Vehtari; Ville-Petteri Mäkinen; Pasi Soininen; Petri Ingman; Sanna M Mäkelä; Markku Savolainen; Minna L Hannuksela; Kimmo Kaski; Mika Ala-Korpela
A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data.
BMC bioinformatics 2007;8 Suppl 2():S8.
2006: Pirjo Koistinen; Satu Ruuska; Marjaana Saily; Sakari Kakko; Pauliina Siitonen; Timo Siitonen; Markku Savolainen; Vuokko L Kinnula; Eeva-Riitta Savolainen
An association between manganese superoxide dismutase polymorphism and outcome of chemotherapy in acute myeloid leukemia.
Haematologica 2006;91(6):829-32.
2006: Markku Savolainen
[Not Available].
Duodecim; lääketieteellinen aikakauskirja 2006;122(10):1247-54.
2006: Eeva H Linna; Juha S Perkiömäki; Mari Karsikas; Tapio Seppänen; Markku Savolainen; Y Antero Kesäniemi; Timo H Mäkikallio; Heikki V Huikuri
Functional significance of KCNH2 (HERG) K897T polymorphism for cardiac repolarization assessed by analysis of T-wave morphology.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2006;11(1):57-62.
2006: M Johanna Liinamaa; Minna L Hannuksela; Mika Rämet; Markku Savolainen
Defective glycosylation of cholesteryl ester transfer protein in plasma from alcohol abusers.
Alcohol and alcoholism (Oxford, Oxfordshire) 2006;41(1):18-23.
2005: Helmut K Seitz; Mikko Salaspuro; Markku Savolainen; Paul Haber; Hiromasa Ishii; Rolf Teschke; Hans Moshage; Charles S Lieber
From alcohol toxicity to treatment.
Alcoholism, clinical and experimental research 2005;29(7):1341-50.
2005: Marja K Liisanantti; Markku Savolainen
Phosphatidylethanol in high density lipoproteins increases the vascular endothelial growth factor in smooth muscle cells.
Atherosclerosis 2005;180(2):263-9.
2005: Ari Tolonen; Tiina M Lehto; Minna L Hannuksela; Markku Savolainen
A method for determination of phosphatidylethanol from high density lipoproteins by reversed-phase HPLC with TOF-MS detection.
Analytical biochemistry 2005;341(1):83-8.
2005: Kaisa Saari; Sari Lindeman; Kaisa Viilo; Matti Isohanni; Marjo-Riitta Järvelin; Liisa H Laurén; Markku Savolainen; Hannu Koponen
A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.
The Journal of clinical psychiatry 2005;66(5):559-63.
2005: S Matthijs Boekholdt; Frank M Sacks; J Wouter Jukema; James Shepherd; Dilys J Freeman; Alex D McMahon; F Cambien; V Nicaud; Greetje J de Grooth; P J Talmud; S E Humphries; George J Miller; Gudny Eiriksdottir; Vilmundur Gudnason; Heikki Kauma; Sakari Kakko; Markku Savolainen; Marcello Arca; Anna Montali; S Liu; H J Lanz; Aeilko H Zwinderman; Jan Albert Kuivenhoven; J J P Kastelein
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
Circulation 2005;111(3):278-87.
2005: K S Kaikkonen; Sakari Kakko; Marja-Leena Kortelainen; J M Tapanainen; Markku Savolainen; Y Antero Kesäniemi; Heikki V Huikuri; Eeva-Riitta Savolainen
The -1C to T polymorphism in the annexin A5 gene is not associated with the risk of acute myocardial infarction or sudden cardiac death in middle-aged Finnish males.
Scandinavian journal of clinical and laboratory investigation 2005;65(2):133-40.
2004: Marja K Liisanantti; Kimmo Huhta; Markku Savolainen
Transfer of phosphatidylethanol between lipoproteins.
Alcoholism, clinical and experimental research 2004;28(11):1638-42.
2004: Kaisa Saari; Jari Jokelainen; Juha Veijola; Hannu Koponen; Peter B Jones; Markku Savolainen; Marjo-Riitta Järvelin; Liisa Lauren; Matti Isohanni; Sari Lindeman
Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey.
Acta psychiatrica Scandinavica 2004;110(4):279-85.
2004: Marja K Liisanantti; Minna L Hannuksela; Mika Rämet; Markku Savolainen
Lipoprotein-associated phosphatidylethanol increases the plasma concentration of vascular endothelial growth factor.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(6):1037-42.
2004: Minna L Hannuksela; Mika Rämet; Antti E T Nissinen; Marja K Liisanantti; Markku Savolainen
Effects of ethanol on lipids and atherosclerosis.
Pathophysiology : the official journal of the International Society for Pathophysiology / ISP 2004;10(2):93-103.
2004: Anna H Karjalainen; Heikki Ruskoaho; Olli Vuolteenaho; Jorma Heikkinen; Ann-Christine Bäckström; Markku Savolainen; Y Antero Kesäniemi
Effects of estrogen replacement therapy on natriuretic peptides and blood pressure.
Maturitas 2004;47(3):201-8.
2004: Vuokko L Kinnula; Siri T Lehtonen; Pirjo Koistinen; Sakari Kakko; Markku Savolainen; Juha Kere; Vesa Ollikainen; Tarja Laitinen
Two functional variants of the superoxide dismutase genes in Finnish families with asthma.
Thorax 2004;59(2):116-9.
2004: Maila Penttinen; Ilkka Kantola; Pirjo Nuutila; Aki Hietaharju; Eero Honkanen; Ilkka Kaitila; Leo Niskanen; Markku Savolainen; Jorma Viikari
[Fabry's disease, recommendation for diagnostics, follow up and treatment in Finland].
Duodecim; lääketieteellinen aikakauskirja 2004;120(20):2407-14.
2004: Markku Savolainen; Tuija Huusko; Anna-Maria Keränen; Sari Lindeman; Annakaisa Reponen; Hannu Koponen
[Endocannabinoids multifunctional messenger system in control of pleasure and eating habit].
Duodecim; lääketieteellinen aikakauskirja 2004;120(12):1457-65.
2004: Markku Savolainen
[Is there a risk to discontinue statin treatment? Statins are advantageous also to the elderly].
Duodecim; lääketieteellinen aikakauskirja 2004;120(8):909-10.
2003: Sakari Kakko; Tuija Räisänen; Minna Tamminen; Juhani Airaksinen; Kaj Groundstroem; Tatu Juvonen; Antti Ylitalo; Paavo Uusimaa; Markku Savolainen
Candidate locus analysis of familial ascending aortic aneurysms and dissections confirms the linkage to the chromosome 5q13-14 in Finnish families.
The Journal of thoracic and cardiovascular surgery 2003;126(1):106-13.
2003: Maria E Rämet; Mika Rämet; Qing Lu; Moriah Nickerson; Markku Savolainen; Amy Malzone; Richard H Karas
High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life.
Journal of the American College of Cardiology 2003;41(12):2288-97.
2003: Sakari Kakko; Markku Päivänsalo; Pirjo Koistinen; Y Antero Kesäniemi; Vuokko L Kinnula; Markku Savolainen
The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis.
Atherosclerosis 2003;168(1):147-52.
2003: Seppo M Pöykkö; Olavi Ukkola; Heikki Kauma; Markku Savolainen; Y Antero Kesäniemi
Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects.
Diabetologia 2003;46(4):455-8.
2003: Sakari Kakko; Jani Kelloniemi; Peter von Rohr; Ina Hoeschele; Minna Tamminen; Margaret E Brousseau; Y Antero Kesäniemi; Markku Savolainen
ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease.
Atherosclerosis 2003;166(2):285-90.
2002: Hannu Koponen; Kaisa Saari; Markku Savolainen; Matti Isohanni
Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review.
European archives of psychiatry and clinical neuroscience 2002;252(6):294-8.
2002: Juha T Karvonen; Heikki Kauma; Kari Kervinen; Olavi Ukkola; Maire Rantala; Markku Päivänsalo; Markku Savolainen; Y Antero Kesäniemi
Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men.
Journal of hypertension 2002;20(12):2371-8.
2002: Sakari Kakko; T Elo; J M Tapanainen; Heikki V Huikuri; Markku Savolainen
Polymorphisms of genes affecting thrombosis and risk of myocardial infarction.
European journal of clinical investigation 2002;32(9):643-8.
2002: Eeva Pietilä; Heidi Fodstad; Elmo Niskasaari; Päivi J Laitinen P; Heikki Swan; Markku Savolainen; Y Antero Kesäniemi; Kimmo Kontula; Heikki V Huikuri
Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women.
Journal of the American College of Cardiology 2002;40(3):511-4.
2002: Minna L Hannuksela; Marja K Liisanantti; Markku Savolainen
Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis.
Critical reviews in clinical laboratory sciences 2002;39(3):225-83.
2002: Juha T Karvonen; Heikki Kauma; Kari Kervinen; Maire Rantala; Markku Ikäheimo; Markku Päivänsalo; Markku Savolainen; Y Antero Kesäniemi
Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort.
Journal of internal medicine 2002;251(2):102-10.
2002: Ursula S Schwab; Jyrki J Agren; RH Valve; Merja Hallikainen; Essi S Sarkkinen; M Jauhiainen; Matti K Karvonen; Ullamari Pesonen; Markku Koulu; M I J Uusitupa; Markku Savolainen
The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet.
European journal of clinical nutrition 2002;56(2):149-56.
2001: Kaisa M Yli-Jokipii; Heikki Paavo Kallio; Ursula S Schwab; Hannu M Mykkänen; Juha-Pekka Kurvinen; Markku Savolainen; Raija L Tahvonen
Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response.
Journal of lipid research 2001;42(10):1618-25.
2001: Sakari Kakko; Minna Tamminen; Markku Päivänsalo; Heikki Kauma; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi; Markku Savolainen
Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness.
European journal of clinical investigation 2001;31(7):593-602.
2001: Shivendra D Shukla; Grace Y Sun; W Gibson Wood; Markku Savolainen; C Alling ; J B Hoek
Ethanol and lipid metabolic signaling.
Alcoholism, clinical and experimental research 2001;25(5 Suppl ISBRA):33S-39S.
2001: Olavi Ukkola; P H Erkkilä; Markku Savolainen; Y Antero Kesäniemi
Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus.
Journal of internal medicine 2001;249(5):451-9.
2001: Anna H Karjalainen; M Paassilta; Jorma Heikkinen; Ann-Christine Bäckström; Markku Savolainen; Y Antero Kesäniemi
Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism.
Clinical endocrinology 2001;54(2):165-73.
2001: Joan Ribot; M Rantala; Y A Kesäniemi; Andreu Palou; Markku Savolainen
Weight loss reduces expression of SREBP1c/ADD1 and PPARgamma2 in adipose tissue of obese women.
Pflügers Archiv : European journal of physiology 2001;441(4):498-505.
2000: M Niemi; Kari Kervinen; Heikki Kiviniemi; Olavi Lukkarinen; Atte P Kyllönen; Meeri Apaja-Sarkkinen; Markku Savolainen; MI Kairaluoma; Y Antero Kesäniemi
Apolipoprotein E phenotype, cholesterol and breast and prostate cancer.
Journal of epidemiology and community health 2000;54(12):938-9.
2000: Markku Päivänsalo; Jukka Merikanto; T Jerkkola; Markku Savolainen; AO Rantala; Heikki Kauma; M Lilja; A Reunanen Y; Antero Kesäniemi; Ilkka Suramo
Effect of hypertension and risk factors on diameters of abdominal aorta and common iliac and femoral arteries in middle-aged hypertensive and control subjects: a cross-sectional systematic study with duplex ultrasound.
Atherosclerosis 2000;153(1):99-106.
2000: AO Rantala; M Lilja; Heikki Kauma; Markku Savolainen; A Reunanen; Y Antero Kesäniemi
Gamma-glutamyl transpeptidase and the metabolic syndrome.
Journal of internal medicine 2000;248(3):230-8.
2000: Anna H Karjalainen; Jorma Heikkinen; Markku Savolainen; Ann-Christine Bäckström; Y Antero Kesäniemi
Regulation of plasma low density lipoprotein levels in postmenopausal women.
Atherosclerosis 2000;151(2):559-66.
2000: Anna H Karjalainen; Jorma Heikkinen; Markku Savolainen; Ann-Christine Bäckström; Y Antero Kesäniemi
Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(4):1101-6.
2000: Lars U Gerdes; C Gerdes; K Kervinen; Markku Savolainen; Ib C Klausen; Peter S Hansen; Y A Kesäniemi; Ole Faergeman
The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study.
Circulation 2000;101(12):1366-71.
2000: Marja-Leena Silaste; R Junes; AO Rantala; Heikki Kauma; M Lilja; Markku Savolainen; A Reunanen; Y Antero Kesäniemi
Dietary and other non-pharmacological treatments in patients with drug-treated hypertension and control subjects.
Journal of internal medicine 2000;247(3):318-24.
2000: M Paassilta; Anna H Karjalainen; Kari Kervinen; Markku Savolainen; Jorma Heikkinen; Ann-Christine Bäckström; Y Antero Kesäniemi
Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels.
Atherosclerosis 2000;149(1):157-62.
2000: Maire Rantala; T T Rantala; Markku Savolainen; Y Friedlander; Y Antero Kesäniemi
Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet.
The American journal of clinical nutrition 2000;71(3):713-24.
2000: Markku Savolainen
[Statins--new mechanisms of action and new indications].
Duodecim; lääketieteellinen aikakauskirja 2000;116(24):2833-8.
2000: Antti Ylitalo; K E Juhani Airaksinen; A Hautanen; Markku Kupari; M Carson; Juha Virolainen; Markku Savolainen; Heikki Kauma; Y Antero Kesäniemi; Perrin C White; Heikki V Huikuri
Baroreflex sensitivity and variants of the renin angiotensin system genes.
Journal of the American College of Cardiology 2000;35(1):194-200.
2000: Sakari Kakko; Minna Tamminen; Markku Päivänsalo; Heikki Kauma; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi; Markku Savolainen
Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men.
European journal of clinical investigation 2000;30(1):18-25.
1999: Heikki Kauma; Markku Savolainen; Y A Kesäniemi
Apolipoprotein E, alcohol, and blood pressure: reply to Puddey et al.
American journal of hypertension 1999;12(9 Pt 1):949-50.
1999: T Korhonen; Markku Savolainen; Y Antero Kesäniemi
Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia.
Atherosclerosis 1999;146(1):1-10.
1999: M Niemi; Kari Kervinen; AO Rantala; Heikki Kauma; Markku Päivänsalo; Markku Savolainen; M Lilja; Y Antero Kesäniemi
The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects.
Gut 1999;44(4):557-62.
1999: T Korhonen; Minna L Hannuksela; Seppo Seppänen; Kari Kervinen; Y Antero Kesäniemi; Markku Savolainen
The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment.
European journal of clinical pharmacology 1999;54(12):903-10.
1999: Vilmundur Gudnason; Sakari Kakko; V Nicaud; Markku Savolainen; Y Antero Kesäniemi; Esa Tahvanainen; S Humphries
Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group.
European journal of clinical investigation 1999;29(2):116-28.
1999: AO Rantala; Heikki Kauma; M Lilja; Markku Savolainen; A Reunanen; Y Antero Kesäniemi
Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects.
Journal of internal medicine 1999;245(2):163-74.
1999: Tatu Juvonen; Jukka Juvonen; Markku Savolainen
Is vasculitis a significant component of atherosclerosis?
Current opinion in rheumatology 1999;11(1):3-10.
1998: Heikki Kauma; Markku Savolainen; AO Rantala; M Lilja; Kari Kervinen; A Reunanen; Y Antero Kesäniemi
Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men.
American journal of hypertension 1998;11(11 Pt 1):1334-43.
1998: Markku Päivänsalo; Jukka Merikanto; Markku Savolainen; M Lilja; AO Rantala; Heikki Kauma; A Reunanen; Y Antero Kesäniemi; Ilkka Suramo
Effect of hypertension, diabetes and other cardiovascular risk factors on kidney size in middle-aged adults.
Clinical nephrology 1998;50(3):161-8.
1998: Tapani Rönnemaa; Jukka Marniemi; Markku Savolainen; Y Antero Kesäniemi; C Ehnholm; C Bouchard; Markku Koskenvuo
Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity.
The Journal of clinical endocrinology and metabolism 1998;83(8):2792-9.
1998: Heikki Kauma; Markku Ikäheimo; Markku Savolainen; Tiila-Riikka Kiema; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi
Variants of renin-angiotensin system genes and echocardiographic left ventricular mass.
European heart journal 1998;19(7):1109-17.
1998: AO Rantala; Markku Päivänsalo; Heikki Kauma; M Lilja; Markku Savolainen; A Reunanen; Y Antero Kesäniemi
Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects.
Diabetes care 1998;21(7):1188-93.
1998: M Johanna Liinamaa; Y Antero Kesäniemi; Markku Savolainen
Lipoprotein composition influences cholesteryl ester transfer in alcohol abusers.
Annals of medicine 1998;30(3):316-22.
1998: SM Pikkujämsä; Heikki V Huikuri; K E Juhani Airaksinen; AO Rantala; Heikki Kauma; M Lilja; Markku Savolainen; Y Antero Kesäniemi
Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome.
American journal of hypertension 1998;11(5):523-31.
1998: M Paassilta; Kari Kervinen; AO Rantala; Markku Savolainen; M Lilja; A Reunanen; Y Antero Kesäniemi
Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study.
BMJ (Clinical research ed.) 1998;316(7131):594-5.
1998: Sakari Kakko; Minna Tamminen; Y Antero Kesäniemi; Markku Savolainen
R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity.
Atherosclerosis 1998;136(2):233-40.
1998: Marjaana Säily; Pirjo Koistinen; Markku Savolainen; M Rantala; Eeva-Riitta Savolainen
Expression of interleukin-6 (IL-6) receptor gene in acute myeloblastic leukemia and response of leukemic cells to exogenous IL-6. A comparative study between cell line cells and corresponding native cells.
Growth factors (Chur, Switzerland) 1998;15(4):243-57.
1997: M Johanna Liinamaa; Minna L Hannuksela; Y Antero Kesäniemi; Markku Savolainen
Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2940-7.
1997: Anna H Karjalainen; Jorma Heikkinen; Markku Savolainen; Ann-Christine Bäckström; M Salinto; Y Antero Kesäniemi
Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy.
British journal of obstetrics and gynaecology 1997;104 Suppl 16():38-43.
1997: Arja Korhonen; Mika Ala-Korpela; M Johanna Liinamaa; Jukka Jokisaari; Y Antero Kesäniemi; Markku Savolainen
Assessment of cholesteryl ester transfer protein function in lipoprotein mixtures by 1H NMR spectroscopy.
NMR in biomedicine 1997;10(7):303-8.
1997: M Johanna Liinamaa; Kari Kervinen; Minna L Hannuksela; Y Antero Kesäniemi; Markku Savolainen
Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers.
Alcoholism, clinical and experimental research 1997;21(4):606-12.
1997: Maire Rantala; Markku Savolainen; Kari Kervinen; Y Antero Kesäniemi
Apolipoprotein E phenotype and diet-induced alteration in blood pressure.
The American journal of clinical nutrition 1997;65(2):543-50.
1996: T Korhonen; Markku Savolainen; M Juhani Koistinen; Markku Ikäheimo; Markku Linnaluoto; K Kervinen; Y Antero Kesäniemi
Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women.
Atherosclerosis 1996;127(2):213-20.
1996: Markku Päivänsalo; AO Rantala; Heikki Kauma; M Lilja; A Reunanen; Markku Savolainen; A Kesäniemi; Ilkka Suramo
Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound.
Journal of hypertension 1996;14(12):1433-9.
1996: Tiila-Riikka Kiema; Heikki Kauma; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi; Markku Savolainen
Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure.
Hypertension 1996;28(6):1070-5.
1996: Heikki Kauma; Markku Päivänsalo; Markku Savolainen; AO Rantala; Tiila-Riikka Kiema; M Lilja; A Reunanen; Y Antero Kesäniemi
Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis.
Journal of hypertension 1996;14(10):1183-7.
1996: Essi S Sarkkinen; Ursula S Schwab; Leo Niskanen; M Hannuksela; Markku Savolainen; K Kervinen; A Kesäniemi; M I J Uusitupa
The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance.
European journal of clinical nutrition 1996;50(9):592-8.
1996: Minna Tamminen; Sakari Kakko; Y Antero Kesäniemi; Markku Savolainen
A polymorphic site in the 3' untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity.
Atherosclerosis 1996;124(2):237-47.
1996: Minna L Hannuksela; M Rantala; Y Antero Kesäniemi; Markku Savolainen
Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(2):213-21.
1996: Ursula S Schwab; H M Maliranta; Essi S Sarkkinen; Markku Savolainen; Y A Kesäniemi; M I J Uusitupa
Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women.
Metabolism: clinical and experimental 1996;45(2):143-9.
1996: Heikki Kauma; Markku Savolainen; R Heikkilä; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi
Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors.
Human genetics 1996;97(2):156-62.
1995: T Juvonen; Markku Savolainen; Y A Kesäniemi
Apolipoproteins and gallstone disease.
Annals of medicine 1995;27(5):507-8.
1995: Markku Savolainen; Y Antero Kesäniemi
Effects of alcohol on lipoproteins in relation to coronary heart disease.
Current opinion in lipidology 1995;6(4):243-50.
1995: O Ukkola; Markku Savolainen; Pasi Salmela; K von Dickhoff; Tiila-Riikka Kiema; Y Antero Kesäniemi
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus.
Journal of molecular medicine (Berlin, Germany) 1995;73(6):307-11.
1995: O Ukkola; Markku Savolainen; Pasi Salmela; K von Dickhoff; Y Antero Kesäniemi
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
Atherosclerosis 1995;115(1):99-105.
1995: Tatu Juvonen; Markku Savolainen; MI Kairaluoma; L H Lajunen; S E Humphries; Y Antero Kesäniemi
Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease.
Journal of lipid research 1995;36(4):804-12.
1995: Ursula S Schwab; Leo Niskanen; H M Maliranta; Markku Savolainen; Y A Kesäniemi; M I J Uusitupa
Lauric and palmitic acid-enriched diets have minimal impact on serum lipid and lipoprotein concentrations and glucose metabolism in healthy young women.
The Journal of nutrition 1995;125(3):466-73.
1995: T Korhonen; Markku Savolainen; T Jääskeläinen; Y Antero Kesäniemi
Effect of a synthetic prostaglandin E2 analogue, RS-86505-007, on plasma lipids and lipoproteins in patients with moderate hypercholesterolaemia: efficacy and tolerance of treatment and response in different apolipoprotein polymorphism groups.
European journal of clinical pharmacology 1995;48(2):97-102.
1994: Mika Ala-Korpela; Arja Korhonen; J Keisala; S Hörkkö; P Korpi; L P Ingman; J Jokisaari; Markku Savolainen; Y Antero Kesäniemi
1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma.
Journal of lipid research 1994;35(12):2292-304.
1994: Minna L Hannuksela; M Johanna Liinamaa; Y Antero Kesäniemi; Markku Savolainen
Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers.
Atherosclerosis 1994;110(1):35-44.
1994: O Ukkola; Markku Savolainen; Pasi Salmela; K von Dickhoff; Y Antero Kesäniemi
DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus.
Clinical genetics 1994;46(3):217-27.
1994: K Kervinen; Markku Savolainen; J Salokannel; A Hynninen; J Heikkinen; Christian Ehnholm; M Juhani Koistinen; Y Antero Kesäniemi
Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians.
Atherosclerosis 1994;105(1):89-95.
1993: K Kervinen; Markku Savolainen; J I Heikkilä; Y Antero Kesäniemi
Lovastatin enhances hepatic uptake of low density lipoprotein in humans.
Journal of lipid research 1993;34(11):1975-82.
1993: O Ukkola; Markku Savolainen; Pasi Salmela; K von Dickhoff; Y Antero Kesäniemi
Apolipoprotein B gene DNA polymorphisms are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus.
Clinical genetics 1993;44(4):177-84.
1993: K Kervinen; Markku Savolainen; Y A Kesäniemi
Lp(a) levels increase after ethanol withdrawal.
Alcoholism, clinical and experimental research 1993;17(4):926.
1993: Mika Ala-Korpela; Yrjö Hiltunen; J Jokisaari; Sinikka Eskelinen; K Kiviniity; Markku Savolainen; Y Antero Kesäniemi
A comparative study of 1H NMR lineshape fitting analyses and biochemical lipid analyses of the lipoprotein fractions VLDL, LDL and HDL, and total human blood plasma.
NMR in biomedicine 1993;6(3):225-33.
1992: Minna L Hannuksela; Y Antero Kesäniemi; Markku Savolainen
Evaluation of plasma cholesteryl ester transfer protein (CETP) activity as a marker of alcoholism.
Alcohol and alcoholism (Oxford, Oxfordshire) 1992;27(5):557-62.
1992: Minna L Hannuksela; Y L Marcel; Y Antero Kesäniemi; Markku Savolainen
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.
Journal of lipid research 1992;33(5):737-44.
1992: S Hörkkö; Markku Savolainen; K Kervinen; Y Antero Kesäniemi
Carbamylation-induced alterations in low-density lipoprotein metabolism.
Kidney international 1992;41(5):1175-81.
1992: K Aalto-Setälä; U M Koivisto; Tatu A Miettinen; Helena Gylling; Y A Kesäniemi; Markku Savolainen; Kalevi Pyörälä; T Ebeling; I Mononen; Hannu Turtola
Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland.
Journal of internal medicine 1992;231(3):227-34.
1991: K Kervinen; Markku Savolainen; M J Tikkanen; Y Antero Kesäniemi
Low density lipoprotein derivatization by acetaldehyde affects lysine residues and the B/E receptor binding affinity.
Alcoholism, clinical and experimental research 1991;15(6):1050-5.
1991: K Kervinen; Markku Savolainen; Y Antero Kesäniemi
Multiple changes in apoprotein B containing lipoproteins after ethanol withdrawal in alcoholic men.
Annals of medicine 1991;23(4):407-13.
1991: Yrjö Hiltunen; Mika Ala-Korpela; J Jokisaari; Sinikka Eskelinen; K Kiviniitty; Markku Savolainen; Y Antero Kesäniemi
A lineshape fitting model for 1H NMR spectra of human blood plasma.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1991;21(2):222-32.
1991: Markku Savolainen; T Korhonen; K Aalto-Setälä; Kimmo Kontula; Y Antero Kesäniemi
Screening for a prevalent LDL receptor mutation in patients with severe hypercholesterolaemia.
Human genetics 1991;87(2):125-8.
1991: Markku Savolainen; M Rantala; K Kervinen; L Järvi; K Suvanto; T Rantala; Y Antero Kesäniemi
Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype.
Atherosclerosis 1991;86(2-3):145-52.
1991: K Kervinen; Markku Savolainen; Y Antero Kesäniemi
A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men.
Life sciences 1991;48(22):2183-8.
1991: Markku Savolainen; Y A Kesäniemi
[Alcohol consumption and coronary heart disease in Finland].
Duodecim; lääketieteellinen aikakauskirja 1991;107(15):1260-7.
1990: Markku Savolainen; Minna L Hannuksela; Seppo Seppänen; K Kervinen; Y Antero Kesäniemi
Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity.
European journal of clinical investigation 1990;20(6):593-9.
1990: Markku Savolainen
How does alcohol raise HDL-cholesterol concentration?
Annals of medicine 1990;22(3):141-2.
1987: Markku Savolainen; E Baraona; C S Lieber
Acetaldehyde binding increases the catabolism of rat serum low-density lipoproteins.
Life sciences 1987;40(9):841-6.
1986: Markku Savolainen; E Baraona; M A Leo; C S Lieber
Pathogenesis of the hypertriglyceridemia at early stages of alcoholic liver injury in the baboon.
Journal of lipid research 1986;27(10):1073-83.
1985: C Karsenty; E Baraona; Markku Savolainen; C S Lieber
Effects of chronic ethanol intake on mobilization and excretion of cholesterol in baboons.
The Journal of clinical investigation 1985;75(3):976-86.
1985: P V Luoma; Markku Savolainen; E A Sotaniemi; A J Arranto; R O Pelkonen
Plasma HDL cholesterol and blood glucose in non-insulin-dependent diabetics related to liver lipids and microsomal enzyme activity.
Acta medica Scandinavica 1985;217(5):473-9.
1985: Markku Savolainen; A J Arranto; I E Hassinen; P V Luoma; R O Pelkonen; E A Sotaniemi
Relationship between lipid composition and drug metabolizing capacity of human liver.
European journal of clinical pharmacology 1985;27(6):727-32.
1984: Markku Savolainen; E Baraona; P Pikkarainen; C S Lieber
Hepatic triacylglycerol synthesizing activity during progression of alcoholic liver injury in the baboon.
Journal of lipid research 1984;25(8):813-20.
1984: C S Lieber; Markku Savolainen
Ethanol and lipids.
Alcoholism, clinical and experimental research 1984;8(4):409-23.
1983: P V Luoma; Markku Savolainen; E A Sotaniemi; R O Pelkonen; A J Arranto; C Ehnholm
Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme induction.
Acta medica Scandinavica 1983;214(2):103-9.
1982: A H Pikkukangas; R A Väänänen; Markku Savolainen; I E Hassinen
Precursor supply and hepatic enzyme activities as regulators of triacylglycerol synthesis in isolated hepatocytes and perfused liver.
Archives of biochemistry and biophysics 1982;217(1):216-25.
1982: P V Luoma; E A Sotaniemi; R O Pelkonen; Markku Savolainen; C Ehnholm
Induction and lipoproteins.
Lancet 1982;1(8272):625.
1981: Markku Savolainen; M A Lehtonen; A Ruokonen; I E Hassinen
Postnatal development and sex differences in hepatic phosphatidate phosphohydrolase activity in the rat.
Metabolism: clinical and experimental 1981;30(7):706-11.
1980: Markku Savolainen; I E Hassinen
Effect of ethanol on hepatic phosphatidate phosphohydrolase: dose-dependent enzyme induction and its abolition by adrenalectomy and pyrazole treatment.
Archives of biochemistry and biophysics 1980;201(2):640-5.
1979: H Voltti; Markku Savolainen; V P Jauhonen; I E Hassinen
Clofibrate-induced increase in coenzyme A concentration in rat tissues.
The Biochemical journal 1979;182(1):95-102.
1979: M A Lehtonen; Markku Savolainen; I E Hassinen
Hormonal regulation of hepatic soluble phosphatidate phosphohydrolase. Induction by cortisol in vivo and in isolated perfused rat liver.
FEBS letters 1979;99(1):162-6.
1978: Markku Savolainen; I E Hassinen
Mechanisms for the effects of ethanol on hepatic phosphatidate phosphohydrolase.
The Biochemical journal 1978;176(3):885-92.
1978: V L Kinnula; Markku Savolainen; I Hassinen
Hepatic triacylglycerol and fatty-acid biosynthesis during hypoxia in vivo.
Acta physiologica Scandinavica 1978;104(2):148-55.
1978: V P Jauhonen; Markku Savolainen; kalervo hiltunen; I E Hassinen
Adaptive changes in gluconeogenic enzymes in rat liver and kidney during long-term ethanol ingestion.
Metabolism: clinical and experimental 1978;27(10):1557-65.
1978: kalervo hiltunen; V P Jauhonen; Markku Savolainen; I E Hassinen
Effects of pent-4-enoate on cellular redox state, glycolysis and fatty acid oxidation in isolated perfused rat heart.
The Biochemical journal 1978;170(2):235-40.
1977: Markku Savolainen; kalervo hiltunen; I E Hassinen
Effect of prolonged ethanol ingestion on hepatic lipogenesis and related enzyme activities.
The Biochemical journal 1977;164(1):169-77.
1977: Markku Savolainen
Stimulation of hepatic phosphatidate phosphohydrolase activity by a single dose of ethanol;.
Biochemical and biophysical research communications 1977;75(2):511-8.
1977: Markku Savolainen; V P Jauhonen; I E Hassinen
Effects of clofibrate on ethanol-induced modifications in liver and adipose tissue metabolism: role of hepatic redox state and hormonal mechanisms.
Biochemical pharmacology 1977;26(5):425-31.
1975: V P Jauhonen; Markku Savolainen; I E Hassinen
Cyclic AMP-linked mechanisms in ethanol-induced derangements of metabolism in rat liver and adipose tissue.
Biochemical pharmacology 1975;24(20):1879-83.